Chairman:  Joe Pitts (PA-16)
Public health and quarantine; hospital construction; mental health; biomedical research and development; health information technology, privacy, and cybersecurity; public health insurance (Medicare, Medicaid) and private health insurance; medical malpractice and medical malpractice insurance; the regulation of food, drugs, and cosmetics; drug abuse; the Department of Health and Human Services; the National Institutes of Health; the Centers for Disease Control; Indian Health Service; and all aspects of the above-referenced jurisdiction related to the Department of Homeland Security.



Joe Pitts (PA), Chairman
Brett Guthrie (KY), Vice Chairman
Ed Whitfield (KY)
John Shimkus (IL)
Tim Murphy (PA)
Michael C. Burgess, M.D. (TX)
Marsha Blackburn (TN)
Cathy McMorris Rodgers (WA)
Leonard Lance (NJ)
Morgan Griffith (VA)
Gus Bilirakis (FL)
Billy Long (MO)
Renee Ellmers (NC)
Larry Bucshon (IN)
Susan Brooks (IN)
Chris Collins (NY)
Joe Barton (TX)
Fred Upton (MI) (Ex Officio)


Gene Green (TX), Ranking Member
Eliot L. Engel (NY)
Lois Capps (CA)
Jan Schakowsky (IL)
G. K. Butterfield (NC)
Kathy Castor (FL)
John Sarbanes (MD)
Doris O. Matsui (CA)
Ben Ray Lujan (NM)
Kurt Schrader (OR)
Joseph P. Kennedy, III (MA)
Tony Cardenas (CA)
Frank Pallone, Jr. (NJ) (Ex Officio)

February 27, 2014 | Press Release

Bills Aim to Help Newborns, Trauma Patients, and Veterinarians

February 27, 2014 | ICYMI

Reports of Stimulus Fraud in Texas Spur Committee Investigation into Obama Administration’s Ability to Detect and Prevent Fraud

Letters to CMS, HHS Inspector General Raise Concerns about Screening Process for Facilities Receiving Federal Funds

February 27, 2014 | Press Release

Members and Witnesses Urge Increased Enforcement Measures to Detect and Punish Illegal, Counterfeit Drug Manufacturing and Distribution

February 26, 2014 | Press Release

Multiple Analyses Find Administration’s Proposed Rule Would Lead to More #BrokenPromises, Higher Costs, and Fewer Choices for Seniors  

February 26, 2014 | Press Release

Legality of Administration’s Proposal to Fundamentally Change Popular Prescription Drug Program Remains In Question